Skye Bioscience's latest marketcap:
As of 08/27/2026, Skye Bioscience's market capitalization has reached $8.72 M. According to our data, Skye Bioscience is the 43322th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 8.72 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -50,492,578 |
| Shares Out | 4.43 M |
| EPS (ttm) | -10.24 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2026 |
Skye Bioscience's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 08/27/2026 | $8.72 M | 7.08% | 43322 |
| 12/31/2025 | $24 M | -72.06% | 26860 |
| 12/31/2024 | $85.9 M | 24286 |
Company Profile
About Skye Bioscience, Inc.
Skye Bioscience, Inc. is a biopharmaceutical company dedicated to advancing metabolic health through innovative therapeutics targeting G-protein coupled receptors.
Key Focus Areas
- Lead Product Candidate: Nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1.
- Clinical Development: Currently in Phase 2 trials, evaluating nimacimab both as a standalone therapy and in combination with a GLP-1R agonist (Wegovy).
Corporate Background
Formerly known as Emerald Bioscience, Inc., the company rebranded to Skye Bioscience, Inc. in January 2021. Headquartered in San Diego, California, the company is at the forefront of metabolic health research.
Frequently Asked Questions
-
What is Skye Bioscience's (SKYE) current market cap?As of 08/27/2026, Skye Bioscience (including the parent company, if applicable) has an estimated market capitalization of $8.72 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Skye Bioscience (SKYE) rank globally by market cap?Skye Bioscience global market capitalization ranking is approximately 43322 as of 08/27/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.